New chemo cocktail aims to boost survival in kids with rare lymphoma
NCT ID NCT02845882
First seen Mar 18, 2026 · Last updated Jun 22, 2026 · Updated 16 times
Summary
This phase 3 trial tests a modified chemotherapy regimen for 150 Chinese children and teens newly diagnosed with lymphoblastic lymphoma. The goal is to improve event-free survival compared to earlier results. Participants receive a combination of drugs including prednisone, vincristine, and others over several phases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOBLASTIC LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Children's Medical Center
Shanghai, 200127, China
-
West China Second University Hospital
Chengdu, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
combination chemotherapy (prednisone, vincristine, pegylated-asparaginase, cytarabine, cyclophosphamide, daunorubicin, 6-mercaptopurine, methotrexate)
What this could lead to
If successful, this modified chemotherapy regimen could improve survival rates for children with lymphoblastic lymphoma in China.
What could go wrong
This is a single-country study with 150 participants, so results may not apply broadly. Chemotherapy has significant side effects, and the trial is not testing a cure—ongoing management is still needed.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.